Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
EpigenCare is a biotechnology company headquartered in New York, USA, focused on consumer-facing epigenetics applications. Its core product, SKINTELLI, is a personalized skincare epigenomic test: users collect a non-invasive sample from the surface of their skin with an at-home kit, send it back to the lab, and receive a skin quality analysis report based on targeted next-generation epigenetic sequencing.
Based on the website content, SKINTELLI primarily measures DNA methylation levels, covering skin indicators such as aging, firmness and elasticity, hydration, sun exposure, skin repair, sensitivity response, oxidation/antioxidant status, and pigmentation. Its recommendation engine matches a user’s skin epigenetic profile against a database of skincare ingredients and market products. The algorithm takes into account the epigenetic effects, potential hazards, and absorbability of ingredients to recommend products better suited to the user’s skin condition.
The website mentions that a $99 version of the SKINTELLI personalized skincare DNA test was previously launched, and also includes terms such as Early Access Kit and Limited Beta. However, it does not disclose current official pricing, plan structure, regional shipping availability, or payment methods. From a SaaS or enterprise software evaluation perspective, there is limited information about its software capabilities: no API, team collaboration, role-based permissions, third-party integrations, self-hosted deployment, or enterprise admin console are described.
Its main strength is a differentiated positioning: it uses skin samples rather than saliva samples, which is logically more relevant for assessing skin condition. The report not only provides test results but also attempts to map them to purchasable skincare products, giving it practical value for consumer decision-making. The main drawback is that the product’s current status is not very clear, with much of the site’s information tied to early access and beta-stage messaging. Key issues such as data privacy, biological sample handling, compliance certifications, and validation of testing accuracy are not sufficiently disclosed.
It is best suited for individual consumers willing to try biotech-driven skincare decision-making, as well as brands interested in personalized skincare matching. For users in China, the site does not specify China shipping, Chinese-language support, cross-border payment options, or network accessibility, so its availability can only be considered unknown. Actual use may also be constrained by cross-border sample shipping, payment, and privacy compliance requirements. If implemented domestically, possible alternatives may include skin imaging analysis, personalized skincare consulting, or local genetic/skin testing services.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on epigencare.com official site.
epigencare.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach epigencare.com directly.